dsip mechanism of action Delta Sleep-Inducing Peptide - an overview Inhibition of circulating dipeptidyl-peptidase 3

Proactive peptide use potentially delaying or preventing disease onset

Also known as Body Protection Compound-157, it is composed of 15 amino acids and is considered a peptidergic agent, meaning it has drug-like effects

Patients frequently experience: Fatigue and generalised weakness that persists despite adequate rest Breathlessness on exertion due to anaemia Palpitations and reduced exercise tolerance Pallor of the skin and mucous membranes These symptoms result from megaloblastic anaemia, where impaired DNA synthesis leads to the production of abnormally large, dysfunctional red blood cells with reduced oxygen-carrying capacity

Comprehensive Review A full scientific summary is available via the National Library of Medicine PMC review